Hale David Robert 4
Accession 0001418812-20-000036
Filed
Apr 30, 8:00 PM ET
Accepted
May 1, 5:37 PM ET
Size
26.2 KB
Accession
0001418812-20-000036
Insider Transaction Report
- Tax Payment
Common Shares, no par value
2020-04-29$18.11/sh−624$11,301→ 10,009 total - Award
Common Shares, no par value
2020-05-01+11,037→ 21,046 total
- 948,353(indirect: See Footnotes)
Common Shares, no par value
- 16,983,241(indirect: See Footnotes)
Common Shares, no par value
- Award
Common Shares, no par value
2020-05-01+11,037→ 21,046 total - Tax Payment
Common Shares, no par value
2020-04-29$18.11/sh−624$11,301→ 10,009 total
- 948,353(indirect: See Footnotes)
Common Shares, no par value
- 16,983,241(indirect: See Footnotes)
Common Shares, no par value
- Award
Common Shares, no par value
2020-05-01+11,037→ 21,046 total - Tax Payment
Common Shares, no par value
2020-04-29$18.11/sh−624$11,301→ 10,009 total
- 948,353(indirect: See Footnotes)
Common Shares, no par value
- 16,983,241(indirect: See Footnotes)
Common Shares, no par value
- Award
Common Shares, no par value
2020-05-01+11,037→ 21,046 total - Tax Payment
Common Shares, no par value
2020-04-29$18.11/sh−624$11,301→ 10,009 total
- 948,353(indirect: See Footnotes)
Common Shares, no par value
- 16,983,241(indirect: See Footnotes)
Common Shares, no par value
- Award
Common Shares, no par value
2020-05-01+11,037→ 21,046 total - Tax Payment
Common Shares, no par value
2020-04-29$18.11/sh−624$11,301→ 10,009 total
- 948,353(indirect: See Footnotes)
Common Shares, no par value
- 16,983,241(indirect: See Footnotes)
Common Shares, no par value
- Tax Payment
Common Shares, no par value
2020-04-29$18.11/sh−624$11,301→ 10,009 total - Award
Common Shares, no par value
2020-05-01+11,037→ 21,046 total
- 16,983,241(indirect: See Footnotes)
Common Shares, no par value
- 948,353(indirect: See Footnotes)
Common Shares, no par value
- Tax Payment
Common Shares, no par value
2020-04-29$18.11/sh−624$11,301→ 10,009 total - Award
Common Shares, no par value
2020-05-01+11,037→ 21,046 total
- 948,353(indirect: See Footnotes)
Common Shares, no par value
- 16,983,241(indirect: See Footnotes)
Common Shares, no par value
- Tax Payment
Common Shares, no par value
2020-04-29$18.11/sh−624$11,301→ 10,009 total - Award
Common Shares, no par value
2020-05-01+11,037→ 21,046 total
- 948,353(indirect: See Footnotes)
Common Shares, no par value
- 16,983,241(indirect: See Footnotes)
Common Shares, no par value
- Award
Common Shares, no par value
2020-05-01+11,037→ 21,046 total - Tax Payment
Common Shares, no par value
2020-04-29$18.11/sh−624$11,301→ 10,009 total
- 948,353(indirect: See Footnotes)
Common Shares, no par value
- 16,983,241(indirect: See Footnotes)
Common Shares, no par value
Footnotes (6)
- [F1]This number represents common shares, no par value, of the Issuer ("Common Shares") withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units ("RSUs").
- [F2]All board compensation accrues to the benefit of the investors in ValueAct Capital Master Fund, L.P., and not to any individual. Under an agreement with ValueAct Capital, D. Robert Hale is deemed to hold the restricted share units for the benefit of the limited partners of ValueAct Capital Master Fund, L.P. and indirectly for the entities listed in (i) to (vi) footnote 5 herein.
- [F3]Each reporting person listed herein disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that such person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
- [F4]Represents the award of RSUs granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $200,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in Common Shares.
- [F5]The securities reported herein are held by ValueAct Capital Master Fund, L.P. and may be deemed to be indirectly beneficially owned by (i) VA Partners I, LLC as General Partner of ValueAct Capital Master Fund, L.P., (ii) ValueAct Capital Management, L.P. as the manager of ValueAct Capital Master Fund, L.P., (iii) ValueAct Capital Management, LLC as General Partner of ValueAct Capital Management, L.P., (iv) ValueAct Holdings, L.P. as the majority owner of the membership interests of VA Partners I, LLC, (v) ValueAct Holdings II, L.P. as the sole owner of the membership interests of ValueAct Capital Management, LLC and as the majority owner of the limited partnership interests of ValueAct Capital Management, L.P., and (vi) ValueAct Holdings GP, LLC as General Partner of ValueAct Holdings, L.P. and ValueAct Holdings II, L.P.
- [F6]The securities reported herein are directly beneficially owned by ValueAct Co-Invest Master Fund, L.P. and may be deemed to be indirectly beneficially owned by (i) VA Partners I, LLC as General Partner of ValueAct Co-Invest Master Fund, L.P. , (ii) ValueAct Capital Management, L.P. as the manager of ValueAct Co-Invest Master Fund, L.P. , (iii) ValueAct Capital Management, LLC as General Partner of ValueAct Capital Management, L.P., (iv) ValueAct Holdings, L.P. as the majority owner of the membership interests of VA Partners I, LLC, (v) ValueAct Holdings II, L.P. as the sole owner of the membership interests of ValueAct Capital Management, LLC and as the majority owner of the limited partnership interests of ValueAct Capital Management, L.P., and (vi) ValueAct Holdings GP, LLC as General Partner of ValueAct Holdings, L.P. and ValueAct Holdings II, L.P.
Documents
Issuer
Bausch Health Companies Inc.
CIK 0000885590
Related Parties
1- filerCIK 0001635643
Filing Metadata
- Form type
- 4
- Filed
- Apr 30, 8:00 PM ET
- Accepted
- May 1, 5:37 PM ET
- Size
- 26.2 KB